SERPINE2 Antibody

What is SERPINE2 and why is it important in research?

SERPINE2 is a serine protease inhibitor belonging to the serpin family, specifically clade E (nexin, plasminogen activator inhibitor type 1), member 2. It plays critical roles in extracellular matrix remodeling and various physiological processes. Research interest in SERPINE2 has grown significantly due to its involvement in multiple pathological conditions. SERPINE2 has been shown to be overexpressed in breast cancer and contributes to metastatic spread by affecting the tumor microenvironment (TME) . Additionally, SERPINE2 is highly expressed in cardiac fibrosis models and appears to contribute to collagen deposition . In reproductive biology, SERPINE2 is highly expressed in the endometrium during the secretory phase, suggesting its role in tissue remodeling .

When designing research involving SERPINE2, consider its molecular weight (calculated at 44 kDa, but observed at 44-50 kDa in experiments) and its potential to form complexes with various proteases, which may appear at higher molecular weights (~75 kDa) in Western blots .

What are the common applications for SERPINE2 antibodies in research?

SERPINE2 antibodies have been validated for multiple research applications, with specific dilution recommendations for each method:

These applications have been validated in multiple sample types including human, mouse, and rat tissues and cell lines such as A549, MCF-7, and C6 cells . When designing experiments, it's recommended to optimize antibody concentration for each specific application and sample type to obtain optimal results.

How should I store and handle SERPINE2 antibodies to maintain their efficacy?

For optimal antibody performance, SERPINE2 antibodies should be stored at -20°C, where they typically remain stable for one year after shipment. The standard storage buffer contains PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 . Some preparations may contain 0.1% BSA for additional stability.

What controls should I include when using SERPINE2 antibodies in experimental validation?

Robust experimental design with SERPINE2 antibodies requires multiple types of controls:

• Positive Controls: Include samples known to express SERPINE2, such as:

  • A549 cells, MCF-7 cells, or C6 cells for Western blot

  • Rat brain or heart tissue

  • Human testis tissue for IHC/IF applications

• Negative Controls:

  • Primary antibody omission control

  • Isotype-matched irrelevant antibody control

  • SERPINE2 knockdown samples (if available)

• Specificity Controls:

  • Pre-absorption with recombinant SERPINE2 protein

  • Testing multiple SERPINE2 antibodies targeting different epitopes

  • Comparing commercial antibodies with well-characterized homemade antibodies

Research has shown that homemade anti-SERPINE2 antibodies raised against highly purified proteins may provide superior specificity and sensitivity compared to some commercial antibodies . If critical results depend on SERPINE2 detection, consider validating findings with multiple antibodies or complementary approaches like mRNA detection.

How should I optimize SERPINE2 antibody dilution for my specific experiment?

Optimization of SERPINE2 antibody dilution is critical for obtaining specific signals with minimal background. While manufacturers provide recommended dilution ranges (e.g., 1:500-1:1000 for WB, 1:20-1:200 for IHC) , these should be considered starting points rather than definitive values.

For systematic optimization:

• Titration Series: Prepare a series of antibody dilutions spanning and extending beyond the recommended range.

• Sample Selection: Use samples with known high, medium, and low expression of SERPINE2, along with a negative control.

• Protocol Consistency: Keep all other variables constant (blocking reagents, incubation times, detection methods).

• Evaluation Criteria:

  • Signal-to-noise ratio

  • Specificity (single band at expected MW for WB)

  • Reproducibility across replicates

  • Correlation with expected expression patterns

For IHC/IF applications, antigen retrieval methods significantly impact results. For SERPINE2 detection, TE buffer pH 9.0 is suggested, with citrate buffer pH 6.0 as an alternative . Both methods should be compared when establishing protocols for new tissue types.

How can I verify the specificity of SERPINE2 antibodies in my experimental system?

Verifying antibody specificity is crucial for reliable research outcomes, especially given the challenges reported with commercial SERPINE2 antibodies . A comprehensive validation approach includes:

• Western Blot Analysis:

  • Confirm detection of proteins at the expected molecular weight (44-50 kDa for SERPINE2)

  • Identify known SERPINE2-protease complexes at higher molecular weights (~75 kDa)

  • Compare detection pattern with multiple antibodies targeting different epitopes

• Genetic Validation:

  • Test antibody reactivity in SERPINE2 knockdown or knockout systems

  • Published studies have used SERPINE2 shRNA or RNAi-lentivirus for knockdown validation

• Recombinant Protein Testing:

  • Use purified recombinant SERPINE2 as a positive control

  • Perform competitive binding assays with recombinant SERPINE2

• Cross-Reactivity Assessment:

  • Test antibody on tissues/cells from multiple species to confirm predicted reactivity

  • Research indicates SERPINE2 antibodies can show cross-reactivity between human, mouse, and rat samples

When evaluating commercial antibodies, consider that antibodies produced using highly purified native proteins as immunogens may offer superior specificity compared to those raised against peptides or E. coli-expressed proteins .

How can SERPINE2 antibodies be used to study extracellular matrix remodeling?

SERPINE2 plays a significant role in extracellular matrix (ECM) remodeling, making it a valuable target for studying this process. Advanced research applications include:

• Immunofluorescence Co-localization Studies:

  • Use SERPINE2 antibodies (1:50-1:500 dilution) alongside ECM markers (collagen, fibronectin) to visualize spatial relationships

  • Multiphoton imaging can reveal changes in collagen architecture associated with SERPINE2 expression/inhibition

• In Vivo Matrix Remodeling Studies:

  • Research has demonstrated that SERPINE2 knockdown or antibody treatment leads to dense extracellular collagen I matrix encapsulation around tumors

  • Multiphoton intravital imaging can visualize these ECM changes directly in animal models

• Complex Formation Analysis:

  • SERPINE2 forms complexes with serine proteases involved in ECM remodeling

  • Immunoprecipitation with SERPINE2 antibodies (0.5-4.0 μg for 1.0-3.0 mg protein) can isolate these complexes for proteomic analysis

  • Researchers have successfully used antibodies targeting specific regions of SERPINE2 to pull down SERPINE2/protease complexes from conditioned media

• Functional Blocking Studies:

  • Specialized antibodies (like Ab11) that target regions involved in SERPINE2/LRP1 interactions can block SERPINE2 function

  • These approaches provide mechanistic insights beyond simple expression analysis

These methods can reveal how SERPINE2 contributes to pathological matrix remodeling in conditions like cardiac fibrosis, where serpinE2 has been shown to promote collagen deposition .

What role does SERPINE2 play in cancer research, and how can antibodies help investigate this?

SERPINE2 has emerged as an important factor in cancer progression, particularly in metastasis. Research applications of SERPINE2 antibodies in cancer research include:

• Tumor Microenvironment Analysis:

  • SERPINE2 affects the tumor microenvironment by influencing ECM remodeling

  • IHC/IF studies with SERPINE2 antibodies can map its distribution within tumor and stromal compartments

  • Research has shown that blocking SERPINE2 dramatically changes the TME, leading to collagen encapsulation and reduced metastasis

• Macrophage Interaction Studies:

  • SERPINE2 expression correlates with tumor-promoting macrophage populations

  • IF co-staining with SERPINE2 and macrophage markers can reveal spatial relationships

  • Studies have demonstrated that SERPINE2 knockdown or antibody treatment reduces tumor-promoting macrophages and decreases chemokine ligand 2

• Metastasis Research:

  • SERPINE2 facilitates metastatic spread, specifically by affecting intravasation rather than extravasation

  • Blocking antibodies like Ab11, which target the LRP1-binding region of SERPINE2, can inhibit metastatic dissemination

  • Techniques combining SERPINE2 antibodies with circulating tumor cell analysis can differentiate effects on intravasation vs. extravasation

• Therapeutic Target Validation:

  • Function-blocking SERPINE2 antibodies that bind to critical functional domains can serve as proof-of-concept for therapeutic approaches

  • Research has demonstrated that such antibodies can reduce metastatic dissemination in breast cancer models

These applications demonstrate how SERPINE2 antibodies contribute to understanding the mechanistic role of this protein in cancer progression beyond simple detection of expression levels.

How do researchers use SERPINE2 antibodies to investigate signaling pathways?

SERPINE2 functions within complex signaling networks that regulate extracellular protease activity and cellular behavior. Advanced applications for studying these pathways include:

• Receptor Interaction Analysis:

  • SERPINE2/protease complexes bind to LRP1 (Low-density lipoprotein receptor-related protein 1), activating signaling

  • Co-immunoprecipitation with SERPINE2 antibodies can identify associated receptors and signaling components

  • Research has developed antibodies specifically targeting the LRP1-binding region of SERPINE2 to disrupt this interaction

• Regulatory Pathway Investigation:

  • SERPINE2 expression is regulated by specific transcription factors

  • ChIP assays using antibodies against transcription factors like Elk1 have revealed binding sites in the SERPINE2 promoter region

  • Research has identified that Elk1 binds to specific regions (-962 to -716 bp and -349 to -53 bp) upstream of the SERPINE2 promoter

• Signaling Cascade Analysis:

  • The ERK1/2 pathway has been implicated in regulating SERPINE2 expression

  • Combined approaches using ERK inhibitors/siRNA with SERPINE2 antibodies for detection have demonstrated this relationship

  • Studies have shown that siRNA-ERK1 transfection prevents AngII-induced upregulation of SERPINE2

• Secretion and Internalization Studies:

  • SERPINE2 is secreted by various cell types and its extracellular levels are regulated through LRP1-mediated endocytosis

  • ELISA assays using SERPINE2 antibodies can quantify secretion levels

  • Research has demonstrated increased SERPINE2 secretion from cardiac fibroblasts after AngII stimulation (1.63-fold and 1.92-fold increases at 24h and 48h, respectively)

These approaches have revealed that SERPINE2 functions within a network involving ERK1/2 signaling, Elk1 transcription factor, and LRP1-mediated cellular uptake, providing deeper understanding of its biological functions.

What are common challenges when detecting SERPINE2 in different sample types?

Researchers face several challenges when detecting SERPINE2 across different experimental contexts:

• Antibody Specificity Issues:

  • Commercial antibodies may show varying levels of specificity and sensitivity

  • Research has demonstrated that some commercial anti-SERPINE2 antibodies produce numerous non-specific bands in Western blots of endometrial tissue

  • Consider using antibodies raised against highly purified native proteins rather than peptides or E. coli-expressed proteins for better specificity

• Complex Formation Detection:

  • SERPINE2 forms covalent complexes with target proteases (~75 kDa)

  • These complexes may be mistaken for non-specific bands without proper controls

  • Include positive controls with known SERPINE2/protease complexes when analyzing samples where protease activity is expected

• Species Cross-Reactivity Limitations:

  • While many SERPINE2 antibodies show reactivity across human, mouse, and rat samples , there may be differences in sensitivity

  • When transitioning between model organisms, validate antibody performance in the new species

  • Consider using cross-species conserved epitopes for antibodies intended for multi-species studies

• Tissue-Specific Expression Levels:

  • SERPINE2 expression varies dramatically across tissues and conditions

  • For tissues with low expression, more sensitive detection methods may be required

  • IHC signal amplification systems or higher antibody concentrations may be necessary for low-expressing tissues

• Detection in Complex Matrices:

  • Detecting secreted SERPINE2 in cell culture supernatants or biological fluids presents challenges

  • Consider concentration steps or immunoprecipitation before analysis

  • Research successfully detected SERPINE2 in cell culture supernatants using ELISA assays

Understanding these challenges allows researchers to design appropriate controls and select optimal detection methods for their specific experimental context.

How should SERPINE2 knockdown or overexpression systems be validated with antibodies?

Proper validation of SERPINE2 genetic manipulation is critical for experimental rigor:

• Knockdown Validation Approaches:

  • Western blot analysis using SERPINE2 antibodies should demonstrate significant protein reduction

  • Published studies with serpinE2 shRNA demonstrated protein knockdown of 85% by Western blot

  • ELISA assays with SERPINE2 antibodies can quantify knockdown efficiency in both cellular extracts (72% reduction) and culture supernatants (61% reduction)

  • Multiple detection methods should be used for comprehensive validation

• Overexpression Validation:

  • Western blot should confirm increased SERPINE2 at the expected molecular weight

  • Immunofluorescence can verify cellular localization of overexpressed protein

  • Research has shown that exogenous SERPINE2 administration can be detected by immunofluorescence in recipient cells

  • Controls should distinguish between endogenous and tagged/recombinant SERPINE2

• Functional Validation:

  • Beyond expression level changes, validate functional consequences of manipulation

  • For SERPINE2 knockdown, decreased collagen levels have been observed in both cardiac fibrosis and cancer models

  • For overexpression, increased collagen deposition (1.33-fold at 24h and 1.95-fold at 48h) has been documented

• Off-Target Effect Assessment:

  • Use multiple knockdown approaches (different siRNA/shRNA sequences) targeting SERPINE2

  • Include rescue experiments by reintroducing SERPINE2 resistant to knockdown

  • Monitor expression of closely related serpin family members to confirm specificity

These validation approaches ensure that observed phenotypes genuinely result from SERPINE2 manipulation rather than technical artifacts or off-target effects.

What strategies can resolve conflicting results when using different SERPINE2 antibodies?

When different SERPINE2 antibodies yield conflicting results, systematic troubleshooting approaches include:

• Epitope Mapping Analysis:

  • Different antibodies target distinct epitopes that may be differentially accessible in certain contexts

  • Commercial SERPINE2 antibodies and homemade antisera may target different regions

  • Map the epitopes recognized by each antibody and consider whether protein modifications, interactions, or conformational changes might affect epitope accessibility

• Antibody Validation Comparison:

  • Evaluate the validation data for each antibody, including knockout/knockdown controls

  • Research has demonstrated that antibodies produced using highly purified proteins as immunogens may provide superior specificity compared to peptide-based antibodies

  • Consider the recombinant expression system used for the immunogen (bacterial vs. mammalian)

• Methodological Optimization:

  • Different antibodies may require specific conditions for optimal performance

  • Systematically vary sample preparation methods (lysis buffers, fixation methods)

  • For IHC, compare antigen retrieval methods (TE buffer pH 9.0 vs. citrate buffer pH 6.0)

• Complementary Approaches:

  • Supplement antibody-based detection with non-antibody methods

  • RT-qPCR for mRNA quantification can confirm expression patterns

  • Mass spectrometry-based proteomics can provide antibody-independent verification

• Functional Validation:

  • Design experiments to test whether observed signals correlate with known SERPINE2 functions

  • Use functional assays such as protease inhibition to confirm the biological relevance of detected signals

By systematically addressing these aspects, researchers can resolve discrepancies and determine which antibody provides the most reliable results for their specific experimental system.

How are SERPINE2 antibodies being used to study disease mechanisms beyond cancer?

SERPINE2 research extends beyond cancer to several other pathological conditions:

• Cardiac Fibrosis Research:

  • SERPINE2 is overexpressed in pressure-overload cardiac fibrosis models

  • SERPINE2 antibodies have revealed increased expression in transverse aortic constriction (TAC) models

  • Knockdown studies have demonstrated that reducing SERPINE2 inhibits collagen deposition and expression of fibrotic markers (α-SMA, collagen I)

  • These findings suggest SERPINE2 as a potential therapeutic target for cardiac fibrosis

• Reproductive Biology Applications:

  • SERPINE2 is highly expressed in endometrial tissue during the secretory phase

  • Immunohistochemistry with SERPINE2 antibodies has mapped its expression patterns in reproductive tissues

  • This suggests roles in endometrial remodeling and reproductive processes

  • Future research may explore SERPINE2's functions in fertility and pregnancy complications

• Neurological Research:

  • SERPINE2 expression has been detected in rat brain tissue

  • While not extensively covered in the provided search results, SERPINE2's role as a protease inhibitor suggests potential neuroprotective functions

  • Future research may investigate its role in neuroinflammation and neurodegenerative diseases

• Fibrotic Disorders Beyond Cardiac Tissue:

  • The mechanisms identified in cardiac fibrosis (ERK1/2 signaling, Elk1 transcription factor regulation) may extend to other fibrotic conditions

  • SERPINE2 antibodies could help investigate its role in pulmonary, hepatic, or renal fibrosis

These diverse applications highlight SERPINE2's broad biological significance and the utility of specific antibodies for investigating its roles across multiple disease contexts.

What novel antibody-based techniques are advancing SERPINE2 research?

Innovative antibody-based approaches are expanding SERPINE2 research capabilities:

• Function-Blocking Antibodies:

  • Antibodies targeting specific functional domains can block SERPINE2 activity

  • Research has developed antibodies (Ab11) targeting a 12-amino acid peptide required for LRP1-mediated internalization of SERPINE2/protease complexes

  • These antibodies not only detect SERPINE2 but also modulate its function, serving as both research tools and potential therapeutic prototypes

• Live-Cell Imaging Applications:

  • Fluorescently labeled non-blocking SERPINE2 antibodies or antibody fragments

  • Allow tracking of SERPINE2 secretion, internalization, and trafficking in living cells

  • Combine with multiphoton intravital imaging to visualize SERPINE2-mediated processes in vivo

• Proximity Ligation Assays (PLA):

  • Detect protein-protein interactions involving SERPINE2 in situ

  • Can visualize SERPINE2 interactions with proteases and receptors with spatial resolution

  • Particularly valuable for studying SERPINE2/protease complex formation and receptor binding

• Antibody-Based Biosensors:

  • SERPINE2 antibody fragments incorporated into FRET-based biosensors

  • Allow real-time monitoring of SERPINE2 activity and interactions

  • Potential applications in high-throughput screening for SERPINE2 modulators

These advanced techniques extend SERPINE2 research beyond simple detection to functional studies and real-time monitoring of its biological activities.

How do researchers interpret contradictions between SERPINE2 protein levels and functional outcomes?

Interpreting discrepancies between SERPINE2 expression and function requires consideration of several factors:

• Post-Translational Modifications:

  • SERPINE2 function may be regulated by modifications not reflected in total protein levels

  • Antibodies specific to modified forms of SERPINE2 could help resolve such discrepancies

  • Consider phosphorylation, glycosylation, or other modifications that might affect activity

• Complex Formation Analysis:

  • SERPINE2 forms covalent complexes with target proteases

  • The balance between free SERPINE2 and SERPINE2/protease complexes may be more functionally relevant than total SERPINE2 levels

  • Western blots can detect both free SERPINE2 (44-50 kDa) and complexes (~75 kDa)

  • Quantifying the ratio between these forms may explain functional differences

• Microenvironmental Factors:

  • Local protease concentrations may affect SERPINE2 function regardless of its expression level

  • SERPINE2 functionality depends on the protease landscape in specific tissues

  • Research has shown that SERPINE2's effects on tumor metastasis involve complex interactions with the extracellular matrix and immune cells

• Receptor Availability:

  • SERPINE2/protease complexes are cleared and signal through receptors like LRP1

  • Receptor expression levels may create bottlenecks in SERPINE2 function

  • Blocking the interaction between SERPINE2 and LRP1 with specific antibodies affects functional outcomes

• Threshold Effects:

  • Some SERPINE2 functions may require minimal protein levels, with additional expression providing no further effect

  • Research shows that exogenous SERPINE2 administration at specific concentrations (10 ng/ml) significantly increases collagen production

Understanding these complexities helps researchers design experiments that go beyond simple correlation analyses to mechanistic studies that clarify how SERPINE2 levels translate to biological effects.

What are the best practices for selecting and validating SERPINE2 antibodies for specific research applications?

Researchers should follow these guidelines when selecting and validating SERPINE2 antibodies:

• Application-Specific Selection:

  • Choose antibodies validated for your specific application (WB, IHC, IP, IF)

  • Consider whether native epitope recognition is critical for your application

  • Research has shown significant differences in performance between antibodies raised against purified proteins versus peptides

• Multi-Layer Validation:

  • Verify antibody specificity using positive and negative controls

  • Confirm specific detection of the expected molecular weight protein (44-50 kDa for SERPINE2)

  • Validate using genetic approaches (knockdown/knockout samples where possible)

  • Commercial antibodies should be compared with well-characterized reference antibodies

• Cross-Reactivity Assessment:

  • If working across species, verify antibody performance in each species

  • Many SERPINE2 antibodies work across human, mouse, and rat samples, but sensitivity may vary

• Functional Correlation:

  • Confirm that detected signals correlate with expected biological functions

  • In SERPINE2 research, this might include correlation with collagen production or protease inhibition

• Reporting Standards:

  • Document complete antibody information (manufacturer, catalog number, lot, dilution, validation methods)

  • Include appropriate positive and negative controls in publications

  • Address potential limitations or caveats of the chosen antibody

These best practices enhance research reproducibility and reliability when working with SERPINE2 antibodies.

How should researchers integrate antibody-based detection with other methodologies in SERPINE2 studies?

Comprehensive SERPINE2 research benefits from integrating multiple methodological approaches:

• Multi-Omics Integration:

  • Complement protein detection with transcriptomic analysis of SERPINE2 mRNA

  • Studies have shown that protein and mRNA changes often correlate in SERPINE2 manipulation experiments

  • Consider epigenetic regulation by examining promoter methylation or histone modifications at the SERPINE2 locus

• Functional Assays:

  • Pair antibody-based detection with functional measurements

  • For SERPINE2, this includes:

    • Protease inhibition assays measuring activity against target proteases

    • Collagen deposition quantification (e.g., using Sirius Red staining or Sirius Red collagen assay for supernatants)

    • Cell migration/invasion assays in cancer research contexts

• Genetic Manipulation:

  • Combine antibody detection with genetic approaches:

    • SERPINE2 knockdown/knockout with validated efficiency (85% protein reduction by Western blot)

    • Overexpression studies with appropriate controls

    • Point mutations affecting specific functions (protease binding, receptor interaction)

• Imaging Correlation:

  • Link antibody-based detection with advanced imaging:

    • Multiphoton intravital imaging to visualize extracellular matrix changes

    • Correlative light and electron microscopy to examine ultrastructural localization

    • Live cell imaging to track secretion and endocytosis dynamics

• Systems Biology Approaches:

  • Place SERPINE2 in broader pathway contexts:

    • Identify upstream regulators (e.g., ERK1/2 and Elk1 transcription factor)

    • Map downstream effectors and signaling cascade components

    • Network analysis integrating proteomic and transcriptomic data

This integrated approach provides a comprehensive understanding of SERPINE2 biology beyond what any single methodology could achieve.